Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02620514 · ClinicalTrials.gov registry record · NA
Medication Adherence in Patients With Inflammatory Bowel Disease (IBD)
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT02620514 is a NA study that has completed, run by Emory University. The registered enrollment target is 77 participants.
The verdict
NCT02620514, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
The purpose of this is to formally assess health literacy and medication adherence in participants with Inflammatory bowel disease (IBD). The study also aims to improve medication adherence, health-related quality of life, and disease activity through a 24-week intervention.
Interventions
- BEHAVIORAL Financial Support
- BEHAVIORAL Education and Reminders
- BEHAVIORAL Educational Visit
- BEHAVIORAL Medication Educational Visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02620514
The ClinicalTrials.gov registry entry for NCT02620514 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Financial Support is the first listed.
NCT02620514 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02620514 about?
NCT02620514 is a clinical study titled "Medication Adherence in Patients With Inflammatory Bowel Disease (IBD)". The purpose of this is to formally assess health literacy and medication adherence in participants with Inflammatory bowel disease (IBD). The study also aims to improve medication adherence, health-related quality of life, and disease activity through a 24-week intervention.
What is the current status of trial NCT02620514?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2015-06. Estimated completion is 2016-11-01.
What interventions are being tested in trial NCT02620514?
The interventions under investigation include: Financial Support (BEHAVIORAL), Education and Reminders (BEHAVIORAL), Educational Visit (BEHAVIORAL), Medication Educational Visit (BEHAVIORAL).
Who is sponsoring clinical trial NCT02620514?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.